Mitogen-induced T-cell CD69 expression is a less sensitive measure of T- cell function than [3H]-thymidine uptake

Communications in Clinical Cytometry

Volumn 38, Issue 5, 1999, Pages 244-249

  Hutchinson, Paul ^a   Divola, Lucy A ^a   Holdsworth, Stephen R ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

CD69; Flow cytometry; Immunodeficiency; T cells

Indexed keywords

CD69 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PREDNISOLONE; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; THYMIDINE; TRITIUM;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA SYNTHESIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MITOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; ENTEROTOXINS; FEMALE; FLOW CYTOMETRY; HIV SERONEGATIVITY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MITOGENS; PHYTOHEMAGGLUTININS; SENSITIVITY AND SPECIFICITY; SUPERANTIGENS; THYMIDINE;

HUMAN IMMUNODEFICIENCY VIRUS; STAPHYLOCOCCUS; TRITIUM;

EID: 0033569609     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19991015)38:5<244::AID-CYTO7>3.0.CO;2-M     Document Type: Article

References (23)

1. Primary Immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immunol 1997;109(Suppl) 1.
2. Biselli R, Matricardi PM, D'Amelio R, Fattorossi A. Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes. Scan J Immunol 1992;35:439-447.
3. Caruso A, Licenziati S, Corulli M, Canaris AD, De Francesco MA, Florentini S, Peroni L, Fallacara F, Dima F, Balsari A, Turano A. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997;27:71-76.
4. Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994;15-479-483.
5. Cebrián M, Yägue E, Rincón M, López-Botet M, De Landázuri MO, Sánchez-Madrid E. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988;168:1621-1637.
6. Risso A, Cosulich ME, Rubartelli A, Mazza MR, Bargellesi A. MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors. Eur J Immunol 1989;19:323-328.
7. Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, Phillips JH. Interleukin 2 activation of natural killer cells rapidly induces the expression and phophorylation of the Leu-23 activation antigen. J Exp Med 1988;167:1572-1586.
8. De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994;180:1999-2004.
9. Testi R, Pulcinelli F, Frati L, Gazzaniga PP, Santoni A. CD69 is expressed on platelets and mediates platelet activation and aggregation J Exp Med 1990;172:701-707.
10. Maino VC, Suni MA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte activation. Cytometry 1995;20:127-133.
11. Mardiney M, Brown MR, Fleisher TA. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen-or antigen-induced proliferative capacity in normals. Cytometry 1996;26:305-310.
12. Prince HE, Lape-Nixon M. CD69 expression reliably predicts the anti-CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 1997;4:217-222.
13. Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990;11:453-459.
14. Kraft N, Stein-Oakley A, Atkins RC, Thomson NM. Functional effects of non-lineage antibodies. In: McMichael AJ, editor. Leukocyte typing III. Oxford: Oxford University Press; 1987. p 681.
15. Krowka JF, Cuevas B, Maron DC, Steimer KS, Ascher MS, Sheppard HW. Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrv 1996;11:95-104.
16. Mehta BA, Maino VC. Simultaneous detection of DNA synthesis and cytokine production in staphylococcal enterotoxin B activated CD4+ T lymphocytes by flow cytometry. J Immunol Methods 1997;208:49-59.
17. Perfetto SP, Hickey TE, Blair PJ, Maino VC, Wagner KF, Zhou S, Mayers DL, St. Louis D, June CH, Siegal JN. Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individuals. Cytometry 1997;30:1-9.
18. North ME, Webster AD, Farrant J. Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C. Clin Exp Immunol 1991;85:198-201.
19. Thon V, Wolf HM, Sasgary M, Litzman J, Samstag A, Hauber I, Lokaj J, Eibl MM. Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CDS+ T lymphocytes of common variable immunodeficiency (CVID) patients. Clin Exp Immunol 1997;110:174-181.
20. Johannisson A, Thuvander A, Gadhasson I-L. Activation markers and cell proliferation as indicators of toxicity: a flow cytometric approach. Cell Biol Toxicol 1995;11:355-366.
21. Taylor-Fishwick DA, Siegel JN. Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. Eur J Immunol 1995;25:3125-3221.
22. Sugimara K, Ueda Y, Takeda K, Fukuda S, Tsukahara K, Habu Y, Fujiwara H, Azuma I. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and inlerleukin 2 receptor light chain expression. Eur J Immunol 1989;19:1357-1364.
23. 2+ concentration hut inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25). Cytometry 1988;9:156-163.